Latest News about SRPT
Recent news which mentions SRPT
From Benzinga
 From Benzinga
 
   2 Beaten-Down Stocks to Avoid
   
  
  
  June 27, 2025
  From Motley Fool
 From Benzinga
 
   This Sarepta Therapeutics Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
   
  
  
  June 25, 2025
  From Benzinga
 From TalkMarkets
 From Benzinga
 
   This Sarepta Therapeutics Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday
   
  
  
  June 20, 2025
  From Benzinga
 From Benzinga
 
   Dow Surges Over 300 Points As Iran Signals De-Escalation: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
   
  
  
  June 17, 2025
  From Benzinga
 From Benzinga
 
   Dow Charges 405 Points Higher As Middle East Fears Ease
   
  
  
  June 16, 2025
  From TalkMarkets
 From Benzinga
 
   US Stocks Higher; Dow Jumps Over 400 Points
   
  
  
  June 16, 2025
  From Benzinga
 From Benzinga
 From Wall Street Pit
 
   Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session
   
  
  
  June 16, 2025
  From Benzinga
 From Benzinga
 
   Sarepta Therapeutics Stock Plummets Over 40% On Second Fatal Case Linked To Its Gene Therapy
   
  
  
  June 16, 2025
  From Benzinga
 
   Why Incyte Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
   
  
  
  June 16, 2025
  From Benzinga
 From Benzinga
 
   Ten-Year Data From Roche's Breast Cancer Trial Shows Perjeta-Based Regimen Cuts Death Risk By 17%
   
  
  
  May 13, 2025
  From Benzinga
 From Motley Fool
 
   Benzinga Bulls And Bears: IBM, Novavax, Arm Holdings — And UK Trade Deal Boosts Markets
   
  
  
  May 10, 2025
  From Benzinga
 From Benzinga
 
   Stocks Struggle For Direction Before Fed Decision
   
  
  
  May 07, 2025
  From TalkMarkets
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.